Top Markets
#1 Fake World Assets Fake World Assets +12.13%
#2 B3 (Base) B3 (Base) +7.21%
#3 OriginTrail OriginTrail +5.67%
#4 BasedHype BasedHype +5.04%
#5 Ontology Ontology +3.60%
#6 Dual Dual +3.59%
#7 Audiera Audiera +3.29%
#8 COTI COTI +3.23%
#9 Strategy PP Variable xStock Strategy PP Variable xStock +3.04%
#10 MVL MVL +2.41%
Coin of the day
Fake World Assets Fake World Assets
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc.

1799
Rang in Aktien #20882
Easywell Biomedicals, Inc., together with its subsidiaries, develops,... Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The company develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; TLX-011 for treatment of inflammatory lesions of rosacea; TLX-015 a prevention and treatment medicine for postpartum hemorrhage; TLX-018, a hemorrhage treatment drug; TLX-030, an anti-inflammatory medicine; TLX-47, an anti-inflammatory drug; and TLX-024, an anticonvulsant. It also develops TWB-201 for Parkinson patch; TLX-501, a urinary medicine; and TLX-502, a pneumonia medicine. In addition, the company provides thermometers, medical devices, and health food and products. It has a collaborative development agreement with Handa Pharmaceuticals and Handa Neuroscience, LLC for the development of TLX-050 for the treatment of neurological disorders. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.
Aktienkurs
$0.96033064
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$119.74M
Veränderung (1 Tag)
0.67%
Veränderung (1 Jahr)
-33.99%
Land
TW
Handel Easywell Biomedicals, Inc. (1799)

Kategorie

Healthcare
Preis 1799 mit Marktkapitalisierung von B
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
1799
$0.96033064
Marktkapitalisierung von Easywell Biomedicals, Inc.(1799)
Marktkapitalisierung: $119.74M
Mit Stand August 2026 hat Easywell Biomedicals, Inc. eine Marktkapitalisierung von $119.74M. Das macht Easywell Biomedicals, Inc. laut unseren Daten zum 20882nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Easywell Biomedicals, Inc. von 2007 bis 2026
1799 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 1799 Vermögenswert B Marktkapitalisierung von B Ergebnisse
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
$41,794.77 $119.74M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,352,023.39%
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
$36,464.55 $119.74M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,796,982.88%
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
$33,382.73 $119.74M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,476,070.92%
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
$28,813.90 $119.74M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,000,314.84%
Easywell Biomedicals, Inc. Easywell Biomedicals, Inc.
$22,398.48 $119.74M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,332,271.18%